Deerfield Management Company, L.P. (Series C) Veracyte, Inc. Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.35 Billion
- Q2 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in Veracyte, Inc. stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 625,000 shares of VCYT stock, worth $18 Million. This represents 0.39% of its overall portfolio holdings.
Number of Shares
625,000Holding current value
$18 Million% of portfolio
0.39%Shares
3 transactions
Others Institutions Holding VCYT
# of Institutions
297Shares Held
77.5MCall Options Held
0Put Options Held
17.6K-
Vanguard Group Inc Valley Forge, PA8.1MShares$233 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.79MShares$224 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.24MShares$151 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl3.8MShares$109 Million0.85% of portfolio
-
Wellington Management Group LLP Boston, MA3.47MShares$99.9 Million0.02% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $2.06B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...